← All indications
Cholelithiasis
Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
Subtype terms (3)
More specific conditions that are subtypes of Cholelithiasis in the MeSH hierarchy.
- Cholecystolithiasis
7 drugs approved
- Choledocholithiasis
5 drugs (4 approved, 1 experimental)
- Gallstones
35 drugs (25 approved, 10 experimental)
Drugs by status
Approved for this indication (3)
Phase 4 trials (12)
Phase 3 trials (1)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (22)
- Medstone International
- ZonMw: The Netherlands Organisation for Health Research and Development
- University of Roma La Sapienza
- Dr. Falk Pharma GmbH
- Ege University
- Guangzhou Medical University
- Konya Training and Research Hospital
- Meander Medical Center
- Universidade Federal de Santa Maria
- Utrecht University
- B.P. Koirala Institute of Health Sciences
- University of Copenhagen
- University of Ankara
- Federal University of Santa Catarina
- Hebrew University
- Methodist Cancer Center, Houston, Texas
- Catholic University of Sacred Heart, Rome
- University of Texas, San Antonio
- Guizhou Medical University
- Dutch Digestive Diseases Foundation
- Agis Zorgverzekeringen
- Government of Ireland
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (8)